PDF(879 KB)
PDF(879 KB)
PDF(879 KB)
英夫利昔单抗治疗炎症性肠病的潜在风险
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Potential risk of monoclonal antibody of infliximab for inflammatory bowel disease
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |